ArticleImmunologic research2025

Anlotinib promotes CD4 + T cell infiltration and enhances the anti-tumor effect of PD-1 blockade in lung cancer.

Mengyan Zhang et al.PubMed ↗Publisher ↗

No numbers read from the abstract.